200 related articles for article (PubMed ID: 30144045)
1. mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.
Meena NK; Pattanayak SP; Ben-Nun Y; Benhamron S; Kumar S; Merquiol E; Hövelmeyer N; Blum G; Tirosh B
Immunology; 2018 Dec; 155(4):505-518. PubMed ID: 30144045
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
3. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.
Benhamron S; Tirosh B
Eur J Immunol; 2011 Aug; 41(8):2390-6. PubMed ID: 21674478
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells.
Sakai Y; Kassai H; Nakayama H; Fukaya M; Maeda T; Nakao K; Hashimoto K; Sakagami H; Kano M; Aiba A
Sci Rep; 2019 Feb; 9(1):2799. PubMed ID: 30808980
[TBL] [Abstract][Full Text] [Related]
5. Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice.
Haji N; Riebe I; Aguilar-Valles A; Artinian J; Laplante I; Lacaille JC
Mol Autism; 2020 May; 11(1):29. PubMed ID: 32375878
[TBL] [Abstract][Full Text] [Related]
6. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
8. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.
Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X
Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250
[TBL] [Abstract][Full Text] [Related]
9. TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
Ogórek B; Lam HC; Khabibullin D; Liu HJ; Nijmeh J; Triboulet R; Kwiatkowski DJ; Gregory RI; Henske EP
Hum Mol Genet; 2018 May; 27(9):1654-1663. PubMed ID: 29509898
[TBL] [Abstract][Full Text] [Related]
10. B-cell-specific mammalian target of rapamycin complex 1 activation results in severe osteoarthritis in mice.
Lin XC; Liu X; Li K; Zhao C; Xu S; Zhang Y; Bai XC; Cai DZ
Int Immunopharmacol; 2018 Dec; 65():522-530. PubMed ID: 30408629
[TBL] [Abstract][Full Text] [Related]
11. mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis.
Selen ES; Wolfgang MJ
J Biol Chem; 2021 Jul; 297(1):100884. PubMed ID: 34146544
[TBL] [Abstract][Full Text] [Related]
12. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
13. TSC1 deletion in fibroblasts alleviates lipopolysaccharide-induced acute kidney injury.
Shen J; Cui ZK; Yao F; Li K; Zhang Y; Chen Z; Zhou Y; Xu S; Zhang Y; Jiang W; Zhang H; Tan K; Liu A; Bai X
Clin Sci (Lond); 2018 Oct; 132(19):2087-2101. PubMed ID: 30185506
[TBL] [Abstract][Full Text] [Related]
14. The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation.
Tang X; Angst G; Haas M; Yang F; Wang C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923449
[TBL] [Abstract][Full Text] [Related]
15. Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies.
McEneaney LJ; Tee AR
Adv Genet; 2019; 103():91-118. PubMed ID: 30904097
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways.
Pal R; Xiong Y; Sardiello M
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2977-2986. PubMed ID: 30728291
[TBL] [Abstract][Full Text] [Related]
17. TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42.
Xu S; Zhang Y; Wang J; Li K; Tan K; Liang K; Shen J; Cai D; Jin D; Li M; Xiao G; Xu J; Jiang Y; Bai X
Cell Death Differ; 2018 Sep; 25(9):1549-1566. PubMed ID: 29358671
[TBL] [Abstract][Full Text] [Related]
18. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.
Endres R; Alimzhanov MB; Plitz T; Fütterer A; Kosco-Vilbois MH; Nedospasov SA; Rajewsky K; Pfeffer K
J Exp Med; 1999 Jan; 189(1):159-68. PubMed ID: 9874572
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia.
Di Nardo A; Lenoël I; Winden KD; Rühmkorf A; Modi ME; Barrett L; Ercan-Herbst E; Venugopal P; Behne R; Lopes CAM; Kleiman RJ; Bettencourt-Dias M; Sahin M
Cell Rep; 2020 Jun; 31(12):107780. PubMed ID: 32579942
[TBL] [Abstract][Full Text] [Related]
20. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.
Yu P; Wang Y; Chin RK; Martinez-Pomares L; Gordon S; Kosco-Vibois MH; Cyster J; Fu YX
J Immunol; 2002 May; 168(10):5117-23. PubMed ID: 11994465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
